Changes in pharmacotherapy for acute myocardial infarction. Comparison of two periods;Cambios en los patrones de prescripción de medicamentos en el infarto agudo del miocardio. Comparación de dos períodos

Revista Medica de Chile

Volumn 129, Issue 5, 2001, Pages 481-488

  Prieto D , Juan Carlos ^a   Corbalán H , Ramón ^b   Nazzal N , Carolina ^b   Chávez S , Eduardo ^b   Lanas Z , Fernando ^b   Bartolucci J , Jorge ^b   Cumsille G , Francisco ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b NONE

Author keywords

Adrenergic beta antagonists; Aspirin; Myocardial infarction; Thrombolytic therapy

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES;

EID: 0035351085     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. ISIS I (FIRST INTERNATIONAL STUDY OF INFARCT SURVIVAL COLLABORATIVE GROUP). Randomized trial of intravenous atenolol among 16.027 cases of suspected myocardial infarction. Lancet 1986; 2: 57-66.
2. ISIS-2 (SECOND INTERNATIONAL STUDY OF INFARCT SURVIVAL COLLAUORATIVE GROUP). Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17.187 cases of suspected acute myocardial infarction. Lancet 1988; 2: 349-60.
3. GISSI (GRUPPO ITALIANO PER LO STUDIO DELLA STREPTOCHINASI NELL' INFARTO MIOCARDICO) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397-401.
4. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collatorative overview of early mortality and major morbidity results from all randomised trials of more than 1.000 patients. Fibrinolytic Therapy Trialists'(FTT) Collaborative Group. Lancet 1994; 343: 311-22.
5. PFEFFER MA, BRAUNWALD E, MOYÉ, LA, BASTA L, BROWN J. Cuddy TE et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992; 327: 669-77.
6. THE ACUTE INFARCTION RAMIPRIL EFFFICACY (AIRE) STUDY INVESTIGATORS. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821-8.
7. GRUPPO ITALIANO PER LO STUDIO DELLA SOPRAVVIVENZA NELL' INFARTO MIOCARDICO. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343: 1115-22.
8. ISIS 4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patients with suspected acute myocardial infarction. Lancet 1995; 345:669-85.
9. CHINESE CARDIAC STUDY COLLABORATIVE. GROUP. Oral captopril versus placebo among 13.634 patients with suspected acute myocardial infarction, interim report from the Chinese Cardiac Study. Lancet 1995; 345: 686-7.
10. MATTHEI R, GUARDA E, YOVANOVICH J, CHAMORRO H, PRIETO JC, CORBALÁN R. Recomendaciones para el manejo intrahospitalario del infarto agudo del miocardio. Rev Chil Cardiol 1997; 16: 35-50.
11. GRUPO DE ESTUDIO MULTICÉNTRICO DEL INFARTO (GEMI) ¿Es Posible para la Cardiología Chilena Realizar Estudios Multicéntricos? Rev Chil Cardiol 1993; 12:153-60.
12. MARTÍNEZ M, AGUSTÍ A, ARNAU JM, VIDAL X, LAPORTE JR. Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13 year period. Eur J Clin Pharmacol 1998, 54: 203-8.
13. ROGERS WJ, BOWLBY LJ, CHANDRA NC, FRENCH WJ, GORE J, LAMBREW CT ET AL. Treatment of Myocardial Infarction in the United States (1990-1993). Observations from the National Registry of Myocardial Infarction. Circulation 1994; 90: 2103-14.
14. EUROPEAN SECONDARY PREVENTION STUDY GROUP Translation of clinical trials into practice: a European population-based study of the use of thrombolysis for acute myocardial infarction. Lancet 1996; 347:1203-7.
15. PRIETO JC, CORBALÁN R, CHÁVEZ E, LANAS F, CUMSILLE F, NAZAL C A NOMBRE DEL GRUPO DE ESTUDIO MULTICÉNTRICO DEL INFARTO (GEMI) Infarto Agudo del Miocardio en Hospitales Chilenos. Resultados Finales del estudio GEMI. Rev Méd Chile 1999; 127:763-74.
16. LANAS F, PRIETO JC, CHÁVEZ E, CORBALÁN R, CUMSILLE F. Uso de bloqueadores beta adrenérgicos en el infarto del miocardio. Rev Chil Cardiol 1998; 17: 205-12.
17. KRUMHOLZ H, RADFORD M, WANG Y, CHEN J, MARCINIAK T. Early β-blocker therapy for acute myocardial infarction in elderly patients. Ann Intern Med 1999; 131: 648-54.
18. YUSUF S, ANAND S, AVEZUM A, FLATHER M, COUTINHO M. Treatment for acute myocardial infarction. European Heart Journal 1996; 17: 16-29
19. LATINI R, MAGGIONI AP, FLATHER M, SLEIGHT P, TOGNONI G. ACE inhibitor use in patients with myocardial infarction: summary of evidence from clinical trials. Circulation 1995; 92: 3132-37.
20. MCLAUGHLIN TJ, SOUMERAI SB, WILLISON DJ, GURWITZ JH, BORBAS C, GUADAGNOLI E, ET AL. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med 1996; 156: 799-805.
21. FURBERG CD, PSATY BM, MEYER JV. Nifedipine dose related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326-31.